Author pages are created from data sourced from our academic publisher partnerships and public sources.
The cost‐effectiveness of dapagliflozin versus sulfonylurea as an add‐on to metformin in the treatment of Type 2 diabetes mellitus
- M. Charokopou, P. McEwan, +6 authors M. Roudaut
- Diabetic medicine : a journal of the British…
- 1 July 2015
To assess the cost‐effectiveness of dapagliflozin, a sodium–glucose co‐transporter–2 (SGLT–2) inhibitor, compared with a sulfonylurea, when added to metformin for treatment of UK people with Type 2… Expand
A case study examining the inclusion of children with special educational needs in a mainstream primary school
- L. Callan
The study aims to find out how inclusive one particular primary school is with regard to students with special educational needs. For the purpose of the study the school is called Rose Hill Primary… Expand
Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus from a UK Healthcare System Perspective
BackgroundType 2 diabetes mellitus (T2DM) is a chronic, progressive condition where the primary treatment goal is to maintain control of glycated haemoglobin (HbA1c). In order for healthcare decision… Expand
The Cost-Effectiveness of Dapagliflozin (Forxiga®) Versus Insulin in the Treatment of Type 2 Diabetes Mellitus (T2DM) in England and Wales
The Yo-Yo intermittent recovery test level 1 as a high intensity training tool: aerobic and anaerobic responses.
OBJECTIVE The aim of this study was to investigate the effects of using the Yo-Yo intermittent recovery test level 1 (Yo-Yo IR1) as a high intensity training tool for sedentary university female… Expand